A phase 1 dose-escalation study of XmAb®2513 in patients with relapsed or refractory Hodgkin lymphoma Journal Article
| Authors: | Kumar, A.; Blum, K. A.; Fung, H. C.; Smith, M. R.; Foster, P. A.; Younes, A. |
| Article Title: | A phase 1 dose-escalation study of XmAb®2513 in patients with relapsed or refractory Hodgkin lymphoma |
| Keywords: | adult; cancer survival; clinical article; unclassified drug; drug tolerability; fatigue; cancer recurrence; diarrhea; dose response; drug safety; monotherapy; binding affinity; letter; progression free survival; anemia; nausea; thrombocytopenia; vomiting; antineoplastic activity; hodgkin disease; monoclonal antibodies; monoclonal antibody; drug dose escalation; immunotherapy; phase 1 clinical trial; therapy; drug binding; clinical trials; hodgkin lymphoma; human; male; female; priority journal; xmab 2513 |
| Journal Title: | British Journal of Haematology |
| Volume: | 168 |
| Issue: | 6 |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2015-03-01 |
| Start Page: | 902 |
| End Page: | 904 |
| Language: | English |
| DOI: | 10.1111/bjh.13152 |
| PROVIDER: | scopus |
| PUBMED: | 25271537 |
| DOI/URL: | |
| Notes: | Export Date: 2 April 2015 -- Source: Scopus |
